Cost of Biosimilar Product Development
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract focuses on developing a valuation model to support decisions regarding the introduction of biosimilar and interchangeable biological products to the market. This project aims to provide a comprehensive analysis to inform cost-effective strategies for biosimilar product development, helping guide policy and investment decisions in the pharmaceutical sector. The solicitation is issued by the Office of the Assistant Secretary for Planning and Evaluation, under the NAICS code 921190, with a forecast type indicating future opportunity availability. The contract details, including location and organization type, remain unspecified. Key contacts for the project include Sonal Parasrampuria as the program point of contact and Lydina Battle serving as the contracting officer. The contract was posted on March 11, 2026, emphasizing ongoing planning efforts in evaluating market entry considerations for biosimilars.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
